Testing SRSD216 for people with high lipoprotein (a)
Part of Hormones & metabolism clinical trials.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to sign a consent form and follow study rules.
- You can be any gender or race.
- Your body mass index (BMI) must be between 18 and 40.
- Men cannot donate sperm and women cannot donate eggs during the study and for 3 months after.
- You should not have a history of bleeding problems or blood clots.
- You should not have had cancer (except some minor skin or localized cancers) in the last 3 years.
- You should not have a fever or active infection within the last week before treatment.
- You should not have had major surgery in the last 3 months or plan one during the study.
- You should not have a known allergy to similar drugs.
- Your fasting triglycerides (a type of fat) should be below 500 mg/dL.
- You should not have taken another experimental drug in the last 30 days (or 5 half-lives).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different forms of an experimental medicine called HRS-5346 to see how the body absorbs them. It is for healthy people aged 18 to 45, and the results will help decide which version to use in future studies.
This trial tests whether a new once-daily pill called SAL0137 can safely lower Lp(a), a type of cholesterol that raises heart attack and stroke risk. It's for adults with high Lp(a) and other heart risk factors, like prior heart problems or diabetes.
This study tests an experimental drug called DR10624 compared to a placebo in people with severely high triglycerides (fats in the blood). It aims to see if the drug can safely lower these fats and reduce the risk of related health problems like pancreatitis.
This trial tests a new investigational medicine (SYH2053) for people with high cholesterol or mixed hyperlipidemia who are already on cholesterol-lowering therapy but still have high levels of 'bad cholesterol' (LDL-C). The goal is to see if this add-on treatment can help lower cholesterol further and reduce heart disease risk.
This study tests a new medicine called SRSD107 for people with long-term blockages in heart or leg arteries. It aims to see if the drug can help prevent clots safely.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
Hear when a new Hyperlipoproteinemia (a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.